100 CoNSoLIdATEd INCoME STATEMENT For ThE yEAr ENdEd 31 dECEMbEr 2008 2007 2006 Notes $m $m $m Revenue 31,601 29,559 26,475 Cost of sales 6,598 6,419 5,559 Gross profit 25,003 23,140 20,916 Distribution costs 291 248 226 Research and development 5,179 5,162 3,902 Selling, general and administrative costs 10,913 10,364 9,096 Other operating income and expense 1 524 728 524 Operating profit 1 9,144 8,094 8,216 Finance income 2 854 959 888 Finance expense 2 1,317 1,070 561 Profit before tax 8,681 7,983 8,543 Taxation 3 2,551 2,356 2,480 Profit for the period 6,130 5,627 6,063 Attributable to: Equity holders of the Company 6,101 5,595 6,043 Minority interests 29 32 20 Basic earnings per $0.25 Ordinary Share 4 $4.20 $3.74 $3.86 Diluted earnings per $0.25 Ordinary Share 4 $4.20 $3.73 $3.85 Weighted average number of Ordinary Shares in issue millions 4 1,453 1,495 1,564 Diluted weighted average number of Ordinary Shares in issue millions 4 1,453 1,498 1,570 Dividends declared and paid in the period 21 2,767 2,658 2,217 All activities were in respect of continuing operations.
CoNSoLIdATEd STATEMENT oF rECogNISEd INCoME ANd ExPENSE For ThE yEAr ENdEd 31 dECEMbEr 2008 2007 2006 Notes $m $m $m Profit for the period 6,130 5,627 6,063 Foreign exchange arising on consolidation 1,336 492 922 Foreign exchange differences on borrowings forming net investment hedges 291 40 Gain loss on cash flow hedge in connection with debt issue 1 21 Available for sale gains losses taken to equity 2 9 20 Actuarial loss for the period 1,232 113 108 Tax on items taken directly to reserves 3 368 33 137 Income and expense recognised directly in equity 1,906 342 931 Total recognised income and expense for the period 19 4,224 5,969 6,994 Attributable to: Equity holders of the Company 19 4,176 5,934 6,970 Minority interests 19 48 35 24 $m means millions of US dollars.
ASTRAZENECA ANNuAl REpoRT ANd FoRm 20-F INFoRmATIoN 2008
